Revolax Deep from Across Corp. (Korea Południowa) and Juvederm (Allergan/AbbVie) represent two approaches to cross-linked hyaluronic acid filler formulation. Both are CE marked and widely used by aesthetic practitioners in Europe. This comparison addresses the key clinical and practical differences.
Formaaulation
Both products use BDDE cross-linking of sodium hyaluronate with 0.3% lidocaine. Revolax Deep is formulated at 24mg/ml HA concentration in a monophasic gel. Juvederm products vary in concentration and use either Hylacross or Vycross cross-linking technology depending on the specific product.
Clinical Performance
Both products deliver comparable correction for moderate-to-severe facial lines and volume deficit. Practitioners who have used both often note that Revolax Deep has a slightly firmer consistency, which some prefer for structural applications. Juvederm Voluma using Vycross technology is notably more cohesive and is specifically formulated for cheek augmentation — no single Korean equivalent directly matches this positioning.
Czas trwania
Revolax Deep claims 12–18 months duration, comparable to Juvederm Ultra Plus. Czas trwania in practice depends significantly on treatment area and individual patient metabolism.
Pricing
Revolax Deep is available at EUR 55 na strzykawkę through Korean Fillers EU — a significant cost advantage versus comparable Juvederm products for high-volume practices.